Tram Tran-Johnson

511 total citations
11 papers, 339 citations indexed

About

Tram Tran-Johnson is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Tram Tran-Johnson has authored 11 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 3 papers in Clinical Psychology. Recurrent topics in Tram Tran-Johnson's work include Schizophrenia research and treatment (7 papers), Epilepsy research and treatment (3 papers) and Treatment of Major Depression (3 papers). Tram Tran-Johnson is often cited by papers focused on Schizophrenia research and treatment (7 papers), Epilepsy research and treatment (3 papers) and Treatment of Major Depression (3 papers). Tram Tran-Johnson collaborates with scholars based in United States. Tram Tran-Johnson's co-authors include Larry Ereshefsky, David A. Sack, Ronald N. Marcus, Philippe Auby, Robert D. McQuade, Dan A. Oren, Charlotte Davis, Anne‐Gaëlle Leroy, Robert Fishman and Robert Riesenberg and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Clinical Chemistry.

In The Last Decade

Tram Tran-Johnson

11 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tram Tran-Johnson United States 8 237 143 53 42 28 11 339
Adityanjee India 12 232 1.0× 103 0.7× 64 1.2× 30 0.7× 36 1.3× 28 454
L.S. Volonteri Italy 10 304 1.3× 85 0.6× 94 1.8× 46 1.1× 74 2.6× 17 479
Ari Jaffe United States 11 305 1.3× 50 0.3× 63 1.2× 43 1.0× 18 0.6× 16 429
R.H. Swift United States 8 339 1.4× 293 2.0× 39 0.7× 21 0.5× 24 0.9× 16 486
Dale R. Grothe United States 10 264 1.1× 97 0.7× 66 1.2× 109 2.6× 34 1.2× 19 456
Ann L. Richards United States 6 186 0.8× 47 0.3× 47 0.9× 25 0.6× 48 1.7× 8 302
Patrick T. Donlon United States 13 388 1.6× 150 1.0× 92 1.7× 30 0.7× 30 1.1× 31 569
Mark D. Watanabe United States 7 252 1.1× 84 0.6× 60 1.1× 45 1.1× 33 1.2× 11 414
Michael J. Reinstein United States 8 303 1.3× 187 1.3× 48 0.9× 29 0.7× 10 0.4× 13 386
Jennifer Kern Sliwa United States 12 334 1.4× 74 0.5× 66 1.2× 56 1.3× 16 0.6× 19 419

Countries citing papers authored by Tram Tran-Johnson

Since Specialization
Citations

This map shows the geographic impact of Tram Tran-Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tram Tran-Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tram Tran-Johnson more than expected).

Fields of papers citing papers by Tram Tran-Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tram Tran-Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tram Tran-Johnson. The network helps show where Tram Tran-Johnson may publish in the future.

Co-authorship network of co-authors of Tram Tran-Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Tram Tran-Johnson. A scholar is included among the top collaborators of Tram Tran-Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tram Tran-Johnson. Tram Tran-Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cutler, Andrew J., Tram Tran-Johnson, Amir H Kalali, et al.. (2025). A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned. Psychopharmacology Bulletin. 43(4). 37–69. 1 indexed citations
2.
Lesem, Michael D., Tram Tran-Johnson, Robert Riesenberg, et al.. (2011). Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. The British Journal of Psychiatry. 198(1). 51–58. 90 indexed citations
3.
Casey, Daniel E., David G. Daniel, Carol A. Tamminga, et al.. (2008). Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia. Neuropsychopharmacology. 34(5). 1330–1338. 41 indexed citations
4.
Tran-Johnson, Tram, David A. Sack, Ronald N. Marcus, et al.. (2007). Efficacy and Safety of Intramuscular Aripiprazole in Patients With Acute Agitation. The Journal of Clinical Psychiatry. 68(1). 111–119. 93 indexed citations
5.
Granneman, Richard, Patricia Wozniak, Tram Tran-Johnson, Christopher Silber, & Randall J. Mack. (1997). Population pharmacokinetics of sertindole during long-term treatment of patients with schizophrenia. Schizophrenia Research. 24(1-2). 202–202. 5 indexed citations
6.
Tran-Johnson, Tram, et al.. (1992). Late Life Schizophrenia and Its Treatment: Pharmacologic Issues in Older Schizophrenic Patients. Clinics in Geriatric Medicine. 8(2). 401–410. 14 indexed citations
7.
Pi, Edmond H., et al.. (1991). Saliva and plasma desipramine levels in Asian and Caucasian volunteers.. PubMed. 27(3). 281–4. 7 indexed citations
8.
Ereshefsky, Larry, et al.. (1990). Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen.. PubMed. 26(1). 108–14. 16 indexed citations
9.
Ereshefsky, Larry, Tram Tran-Johnson, & Motoki Watanabe. (1990). Pathophysiologic basis for schizophrenia and the efficacy of antipsychotics.. PubMed. 9(9). 682–707. 15 indexed citations
10.
Ereshefsky, Larry, Tram Tran-Johnson, Charlotte Davis, & Anne‐Gaëlle Leroy. (1988). Pharmacokinetic factors affecting antidepressant drug clearance and clinical effect: evaluation of doxepin and imipramine--new data and review.. Clinical Chemistry. 34(5). 863–880. 43 indexed citations
11.
Sramek, John J., et al.. (1988). A carbamazepine trial in chronic, treatment-refractory schizophrenia. American Journal of Psychiatry. 145(6). 748–750. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026